Blog24 September 2024 Unlocking FDA’s Vision for PRO Collection in RWE: Timing, Methods, and Insights Discover FDA's guidance on collecting PROs for Real-World Evidence (RWE), focusing on timing, methods, and improving data quality. Learn more
Blog11 September 2024 Understanding Phase 4 Clinical Trials: A Critical Component of Post-Marketing Insight to Drugs in the Real-World When it comes to Phase 4 clinical trials, Castor's cutting-edge Real-World Evidence (RWE) platform is your key to... Learn more
Blog9 August 2024 5 Key Takeaways from the FDA’s Real-World Evidence Guidance A deep dive into the evolving regulatory environment, the innovative approaches emerging in RWE, and the critical importance... Learn more
Blog18 July 2024 Navigating the Evolving Regulatory and Data Landscape A deep dive into the evolving regulatory environment, the innovative approaches emerging in RWE, and the critical importance... Learn more
Blog5 July 2024 Do We Still Need Patients in Tomorrow’s Trials? Modeling Placebo Effect and Beyond Discover the transformative role of AI in clinical trials, with expert insights from Derk Arts and MaryAnne Rizk... Learn more
Blog12 June 2024 eCOA: Afterthought or Essential Strategy? An Expert’s View on Choosing and Developing an eCOA Strategy The Evolving Landscape of eCOA in Clinical Trials Clinical trials have long grappled with the complexities of data... Learn more
Event23 May 2024 DIA 2024 Meet us at Booth #2327 June 16 – 20, 2024 | San Diego Convention Center Meet the team at booth #2327 at DIA to discuss your RWE needs, get a demo and see... Learn more
Blog16 May 2024 Evaluating “Bother” as a Component of Patient-Reported Outcomes in Clinical Studies Patient-reported outcome (PRO) instruments refer to multiple scales and questionnaires designed to collect patients’ personal feedback on their... Learn more
Blog1 May 2024 Revolutionizing Blood Pressure Monitoring: Insights from Aktiia and Castor’s Collaboration How Aktiia brought their continuous BP device to market by integrating vast amounts of blood pressure data with... Learn more
Blog12 April 2024 5 Best Practices for Getting Started with ePRO Electronic Patient Reported Outcomes (ePRO) can become a powerhouse for gathering high-quality data directly from patients. To help... Learn more
Blog10 April 2024 Can BYOD help us end an era of waste and burden in eCOA? Bring Your Own Device (BYOD) represents the future of eCOA, and prioritizes flexibility & convenience for trial participants.... Learn more
Blog22 March 2024 Measuring the true patient experience in Cancer Trials with eCOA / ePRO Shedding light on the complexities and advancements in measuring PROs, drug tolerability, and quality of life in cancer... Learn more
Blog9 March 2024 The Place of COAs / PROs in the Future of Healthcare Learn how integrating Patient-Reported Outcomes (PROs) into clinical trials can drive success in Value-Based Care (VBC). Learn more
Blog20 February 2024 Accelerating AI Innovation in Pharma: Collaboration versus Competition Should clinical trial companies collaborate to speed up innovation in AI, or is a healthy dose of competition... Learn more
Blog14 November 2023 10 FAQs on eConsent To gain a deeper understanding of eConsent, we have gathered the 10 most frequently asked questions that address... Learn more
Blog11 October 2023 Don’t Overengineer It: Hybrid Designs Overcome Barriers in DTx Clinical Trials At DTxEast 2023, Castor joined a panel discussion to answer big questions when designing DTx clinical trials Learn more
Blog26 September 2023 A Digital-First Mindset Shift on eConsent eConsent plays a pivotal role in optimizing modern clinical trials, but the nuance around its adoption for pharmaceutical... Learn more
Blog14 August 2023 Preparing Your eConsent Study for IRB Approval In this blog we cover how eConsent benefits trials and aligns with IRB ethical commitments, how to prepare... Learn more
